Clinical Trials Directory

Trials / Unknown

UnknownNCT05850117

Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p

Efficacies of Tetracycline-levofloxacin Quadruple Therapy, Standard Bismuth Quadruple Therapy and Amoxicillin-levofloxacin Quadruple Therapy in the Second-line Treatment of H Pylori Infection

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Kaohsiung Medical University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

1. Compare the efficacy of "Tetracycline combined with levofloxacin quadruple therapy", "standard tincture quadruple therapy" and "amoxicillin combined with levofloxacin quadruple therapy" on the second line of Helicobacter pylori sterilization. 2. To investigate the drug resistance of Helicobacter pylori and the host genotypes of CYP2C19 and IL-1B-511 on the sterilizing effect of three second-line Helicobacter pylori.

Detailed description

The "standard tincture quadruple therapy" and the "proton pump inhibitor combined with fluoroquinolone and amoxicillin triple therapy" recommended by the 5th Mazdock-Florence Consensus Conference on the second line of Helicobacter pylori treatment The sterilization rate is not ideal (less than 80%). Recently, we have developed a "Tetracycline combined with levofloxacin quadruple therapy" for first-line treatment failure of H. pylori infection, with a relatively high sterilization rate (\> 95%). A randomized controlled trial confirmed that the elimination rate of "Tetracycline combined with levofloxacin quadruple therapy" was better than "proton pump inhibitor combined with fluoroquinolone" after "standard triple therapy" and "non-tank tetratherapy" sterilization failure. Triple therapy with amoxicillin.

Conditions

Interventions

TypeNameDescription
DRUGesomeprazole, tripotassium dicitrate bismuthate, tetracycline and levofloxacinTetracycline combined with levofloxacin quadruple therapy
DRUGesomeprazole , tripotassium dicitrate bismuthate, tetracycline 500mg and metronidazolestandard tincture quadruple therapy
DRUGesomeprazole, tripotassium dicitrate bismuthate , amoxicillin and levofloxacinamoxicillin combined with levofloxacin quadruple therapy

Timeline

Start date
2020-02-10
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2023-05-09
Last updated
2023-05-09

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05850117. Inclusion in this directory is not an endorsement.